Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Ibraheim · SciRah

Researcher profile · Semantic Scholar

H. Ibraheim

Share profile

H. Ibraheim — researcher profile on SciRah

h-index: 13
Works: 58
Citations: 692

Most-cited papers

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
J. Alexander, N. Kennedy, H. Ibraheim, S. Anandabaskaran +58 more
2022The Lancet Gastroenterology and Hepatology110 citations Open access
Semantic Scholar
Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
S. Honap, S. Meade, H. Ibraheim, P. Irving +2 more
2021Digestive Diseases and Sciences73 citations
Semantic Scholar
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
J. Alexander, B. Mullish, Nathan P. Danckert, Zhigang Liu +23 more
2023EBioMedicine55 citations Open access
Semantic Scholar
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis.
N. Powell, H. Ibraheim, T. Raine, R. A. Speight +15 more
2020The Lancet Gastroenterology and Hepatology54 citations Open access
Semantic Scholar
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study
J. Alexander, Zhigang Liu, Diana Muñoz Sandoval, C. Reynolds +65 more
2022The Lancet Gastroenterology and Hepatology53 citations Open access
Semantic Scholar
Pathology of immune-mediated tissue lesions following treatment with immune checkpoint inhibitors
H. Ibraheim, E. Perucha, N. Powell
2019Rheumatology50 citations Open access
Semantic Scholar
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
N. Chanchlani, Simeng Lin, D. Chee, B. Hamilton +21 more
2021Journal of Crohn's & Colitis44 citations Open access
Semantic Scholar
Systematic review with meta‐analysis: effectiveness of anti‐inflammatory therapy in immune checkpoint inhibitor‐induced enterocolitis
H. Ibraheim, S. Baillie, M. Samaan, Hamzah Abu-Sbeih +4 more
2020Alimentary Pharmacology and Therapeutics40 citations Open access
Semantic Scholar
Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis
Jonathan W. Lo, D. Cozzetto, James L Alexander, Nathan P. Danckert +15 more
2023Nature Communications33 citations Open access
Semantic Scholar
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
J. Alexander, H. Ibraheim, Bhavisha P. Sheth, J. Little +19 more
2021Journal for ImmunoTherapy of Cancer31 citations Open access
Semantic Scholar
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience
H. Ibraheim, M. Samaan, A. Srinivasan, O. Brain +16 more
2020Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology27 citations Open access
Semantic Scholar
Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients
Ying-Hong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila +27 more
2024Gastrointestinal Endoscopy21 citations Open access
Semantic Scholar
Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease
H. Ibraheim, C. Giacomini, Z. Kassam, F. Dazzi +1 more
2018Expert Review of Gastroenterology & Hepatology21 citations
Semantic Scholar
Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis
H. Ibraheim, Michael Green, S. Papa, N. Powell
2019BMJ Case Reports10 citations Open access
Semantic Scholar
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib
Zhigang Liu, James L. Alexander, Yee-Eng Kai, H. Ibraheim +29 more
2023Journal of Crohn's & Colitis9 citations Open access
Semantic Scholar
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy.
N. Dean, Paolo D. d’Arienzo, H. Ibraheim, K. Lee +3 more
2024Best practice & research. Clinical gastroenterology8 citations
Semantic Scholar
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
J. Alexander, H. Ibraheim, C. Richards, B. Shum +11 more
2022Journal for ImmunoTherapy of Cancer8 citations Open access
Semantic Scholar
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Zhigang Liu, James L. Alexander, K. Le, Xin Zhou +68 more
2023EClinicalMedicine7 citations Open access
Semantic Scholar
Decoding cytokine networks in ulcerative colitis to identify pathogenic mechanisms and therapeutic targets.
M. Olbei, I. Hautefort, John P. Thomas, L. Csabai +11 more
2026Science Signaling6 citations Open access
Semantic Scholar
PTU-009 Upper gastrointestinal inflammation in patients with immune-checkpoint inhibitor induced diarrhoea
Muhammad W Fazal, L. Spain, H. Ibraheim, Nadia Yousaf +5 more
2018IBD6 citations Open access
Semantic Scholar
PWE-025 Microscopic colonic inflammation in immune check point inhibitor-induced diarrhoea/colitis
H. Ibraheim, L. Spain, A. Samani, S. Papa +5 more
2018IBD5 citations Open access
Semantic Scholar
Implementation of an intervention bundle leads to quality improvement in ulcerative colitis endoscopy reporting
R. Kader, R. Dart, G. Sebepos-Rogers, E. Shakweh +33 more
2020GastroHep4 citations Open access
Semantic Scholar
PTU-005 Infliximab use in immune-related diarrhoea/colitis (IRD/C)
L. Spain, J. Clark, L. Au, Ella Daniels +7 more
2018IBD4 citations
Semantic Scholar
Decoding Cytokine Networks in Ulcerative Colitis to Identify Pathogenic Mechanisms and Therapeutic Targets
M. Olbei, I. Hautefort, John P. Thomas, L. Csabai +6 more
2024bioRxiv3 citations
Semantic Scholar
OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab
J. Alexander, N. Kennedy, H. Ibraheim, S. Anandabaskaran +27 more
2022Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
Immune checkpoint inhibitor-induced colitis is mediated by CXCR6+ polyfunctional lymphocytes and is dependent on the IL23/IFNγ axis
Jonathan W. Lo, D. Cozzetto, Zhigang Liu, H. Ibraheim +12 more
20222 citations Open access
Semantic Scholar
PWE-024 Effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced diarrhoea/colitis
H. Ibraheim, M. Samaan, N. Powell
2018IBD2 citations
Semantic Scholar
Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor-induced colitis.
H. Ibraheim, Paolo D d'Arienzo, N. Dean, William Duggleby +19 more
2026European Journal of Cancer1 citations Open access
Semantic Scholar
P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination
J. Alexander, Zhigang Liu, Yee-Eng Kai, H. Ibraheim +16 more
2023Poster presentations1 citations
Semantic Scholar
P001 Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on the IL23/IFNg axis
J. Lo, D. Cozzetto, M. Madgwick, J. Sieh +12 more
2022Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
PTU-006 Incidence of immune check point inhibitor induced diarrhoea/colitis- experience from a multi-centre cohort
L. Spain, A. Samani, H. Ibraheim, L. Au +11 more
2018IBD1 citations Open access
Semantic Scholar
P480 Effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced diarrhoea/colitis
H. Ibraheim, M. Samaan, N. Powell
20181 citations
Semantic Scholar
P175 IL-22-driven inflammatory and drug resistance pathways are JAK1-dependent in a human 3D mini-gut organoid system
A. Saifuddin, H. Ibraheim, D. Cozzetto, Neha Panneer-Selvam +5 more
2026E-Posters0 citations
Semantic Scholar
P211 Infection risk and clinical outcomes in immune checkpoint inhibitor–induced colitis
Dhruv Shah, H. Ibraheim, Paolo Davide d'Arienzo, Nathan James Dean +17 more
2026E-Posters0 citations
Semantic Scholar
A microbiota-responsive polyfunctional cytotoxic CD4⁺ T-cell state promotes mucosal inflammation in ulcerative colitis
John P. Thomas, S. H. Kottoor, Jonathan W. Lo, Tyler Wooldridge +16 more
2026bioRxiv0 citations Open access
Semantic Scholar
1184 Clinical outcomes in patients with endoscopically proven immune checkpoint inhibitor-induced colitis – a multi-centre retrospective study
Paolo D. d’Arienzo, H. Ibraheim, N. Dean, M. Aboulela +8 more
2024Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Tu1734 BLOCKADE OF IL-27, BUT NOT IL-1B, ATTENUATES IMMUNE CHECKPOINT INHIBITOR COLITIS
H. Ibraheim, D. Cozzetto, Hiromi Kudo, R. Goldin +2 more
2024Gastroenterology0 citations
Semantic Scholar
P92 Lumeneye digital proctoscopy is safe and streamlines management of immune checkpoint inhibitor induced colitis
H. Ibraheim, J. Alexander, Sadek Malas, Z. Harrison +2 more
2023Poster presentations0 citations
Semantic Scholar
Sa1931 MOLECULAR PROFILING OF FFPE TISSUE IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR INDUCED COLITIS HIGHLIGHTS NEW THERAPEUTIC TARGETS
H. Ibraheim, D. Cozzetto, Jonathan W. Lo, A. Cortellini +3 more
2023Gastroenterology0 citations
Semantic Scholar
P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy
Z. Liu, J. Alexander, K. Le, X. Zhou +33 more
2023Journal of Crohn's & Colitis0 citations
Semantic Scholar
LUMENEYE DIGITAL PROCTOSCOPY IS SAFE AND REDUCES TIME TO TREATMENT IN IMMUNE CHECKPOINT INHIBITOR INDUCED COLITIS
H. Ibraheim, J. Alexander, Sadek Malas, Z. Harrison +2 more
2023Gastrointestinal Endoscopy0 citations
Semantic Scholar
P77 Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type strain in patients with IBD after three doses of COVID-19 vaccine
Zhigang Liu, J. Alexander, K. Le, Xinyi Zhou +16 more
2023Poster presentations0 citations
Semantic Scholar
374: IMMUNE CHECKPOINT INHIBITOR-INDUCED COLITIS IS MEDIATED BY CYTOTOXIC LYMPHOCYTES AND IS RELIANT ON THE IL23/IFNγ AXIS
Jonathan W. Lo, D. Cozzetto, M. Madgwick, J. Sieh +12 more
2022Gastroenterology0 citations
Semantic Scholar
Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
J. Alexander, Nick Kennedy, H. Ibraheim, S. Anandabaskaran +25 more
2022Gastroenterology0 citations Open access
Semantic Scholar
Su1611: POOR RESPONSE TO ANTI-SARS-COV-2 VACCINATION IN IMMUNOSUPPRESSED INFLAMMATORY BOWEL DISEASE PATIENTS IS ASSOCIATED WITH ALTERED GUT MICROBIOTA FUNCTION
J. Alexander, B. Mullish, Nathan P. Danckert, Zhigang Liu +16 more
2022Gastroenterology0 citations Open access
Semantic Scholar
P009 Integrin-b7+ cytotoxic MAIT cells are expanded in the colon of Ulcerative Colitis patients, correlate with disease severity and are targeted by vedolizumab therapy
S. Hermangild Kottoor, H. Ibraheim, P. Polychronis, B. Senthuran +4 more
2022Journal of Crohn's & Colitis0 citations
Semantic Scholar
P2 COVID-19 vaccination response in immunosuppressed patients with IBD is associated with altered gut microbiota function
J. Alexander, B. Mullish, Nathan P. Danckert, Zhigang Liu +16 more
2022Poster presentations0 citations
Semantic Scholar
792: MICROBIOTA-RESPONSIVE CYTOTOXIC, POLYFUNCTIONAL CD4+ T CELLS ARE ENRICHED IN ULCERATIVE COLITIS AND ARE ASSOCIATED WITH RESISTANCE TO ANTI-CYTOKINE THERAPIES
S. Kottoor, D. Cozzetto, M. Madgwick, M. Olbei +7 more
2022Gastroenterology0 citations
Semantic Scholar
P38 Immune checkpoint inhibitor-induced colitis is mediated by CXCR6+ polyfunctional lymphocytes and dependent on IL23/IFNg axis
Jonathan W. Lo, D. Cozzetto, Zhigang Liu, H. Ibraheim +12 more
2022Poster presentations0 citations
Semantic Scholar
108 INFLIXIMAB TREATMENT FOR CHECKPOINT INHIBITOR INDUCED COLITIS: CLINICAL OUTCOMES FROM A MULTI-CENTRE STUDY
J. Alexander, Bhavisha P. Sheth, H. Ibraheim, J. Little +17 more
20210 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Powell×21
Invite
N. Powell — researcher profile on SciRah
J. Alexander×17
Invite
J. Alexander — researcher profile on SciRah
A. Saifuddin×13
Invite
A. Saifuddin — researcher profile on SciRah
C. Bewshea×13
Invite
C. Bewshea — researcher profile on SciRah

×13

Invite

N. Powell — researcher profile on SciRah

Zhigang Liu×12

Invite

Zhigang Liu — researcher profile on SciRah

Invite

R. Nice — researcher profile on SciRah

Invite

C. Lees — researcher profile on SciRah

Invite

K. Kok — researcher profile on SciRah

Invite

M. Olbei — researcher profile on SciRah

D. Cozzetto×10

Invite

D. Cozzetto — researcher profile on SciRah

L. Constable×9

Invite

L. Constable — researcher profile on SciRah